Abstract

Histamine is a basic amine stored in mast cells, with its release capable of activating one of four histamine receptors. The histamine 3 receptor (H3R) is known to be cardioprotective during acute ischemia by acting to limit norepinephrine release. However, a recent study reported that myofibroblasts isolated from the infarct zone of rat hearts responded to H3R activation by up-regulating collagen production. Thus, it is necessary to clarify the potential role of the H3R in relation to fibrosis in the heart. We identified that the mouse left ventricle (LV) expresses the H3R. Isolation of mouse cardiac fibroblasts determined that while angiotensin II (Ang II) increased levels of the H3R, these cells did not produce excess collagen in response to H3R activation. Using the Ang II mouse model of adverse cardiac remodeling, we found that while H3R blockade had little effect on cardiac fibrosis, activation of the H3R reduced cardiac fibrosis and macrophage infiltration. These findings suggest that when activated, the H3R is anti-inflammatory and anti-fibrotic in the mouse heart and may be a promising target for protecting against cardiac fibrosis.

Highlights

  • Adverse myocardial remodeling, including cardiac fibrosis and cardiomyocyte hypertrophy, can lead to left ventricle (LV) diastolic and systolic dysfunction and eventual heart failure

  • We found that (1) the histamine 3 receptor (H3R) is expressed in the mouse LV; (2) isolated cardiac fibroblasts possess the H3R, which was up-regulated in response to angiotensin II (Ang II); (3) blockade of the H3R with A331440 did not alter cardiac fibrosis or inflammation; and (4) activation of the H3R with imetit significantly reduced cardiac fibrosis and macrophage infiltration

  • Our study identified the expression of the H3R in the mouse heart and established that activation of this receptor can counteract adverse cardiac remodeling induced by Ang II infusion

Read more

Summary

Introduction

Adverse myocardial remodeling, including cardiac fibrosis and cardiomyocyte hypertrophy, can lead to LV diastolic and systolic dysfunction and eventual heart failure. A recent article by Piera et al [17] reported that myofibroblasts isolated from the infarct zone of rat hearts following four weeks of ischemia responded to the H3R agonist imetit by up-regulating collagen production. This indicated a possible long-term pro-fibrotic role for the H3R. We found that (1) the H3R is expressed in the mouse LV; (2) isolated cardiac fibroblasts possess the H3R, which was up-regulated in response to Ang II; (3) blockade of the H3R with A331440 did not alter cardiac fibrosis or inflammation; and (4) activation of the H3R with imetit significantly reduced cardiac fibrosis and macrophage infiltration

The H3R Is Expressed in the Mouse Heart
Effect of H3R Blockade on LV Structure and Function in Ang-II-Infused Mice
H3R Blockade Did Not Alter Cardiac Fibrosis
H3R Blockade Did Not Alter Inflammation
Discussion
Experimental Design
Echocardiography
Isolation and Treatment of Cardiac Fibroblasts
Protein Analysis
Hydroxyproline Assay
Statistical Analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call